XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
REVENUE - Disaggregation of Revenue by Product and Region (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue from External Customer [Line Items]    
Total Revenues $ 11,865 $ 11,337
Performance obligation satisfied in previous period 182 166
United States    
Revenue from External Customer [Line Items]    
Total Revenues 8,476 7,952
International    
Revenue from External Customer [Line Items]    
Total Revenues 3,190 3,230
Other    
Revenue from External Customer [Line Items]    
Total Revenues 199 155
Growth Portfolio    
Revenue from External Customer [Line Items]    
Total Revenues 4,792 4,418
Opdivo    
Revenue from External Customer [Line Items]    
Total Revenues 2,078 2,202
Orencia    
Revenue from External Customer [Line Items]    
Total Revenues 798 764
Yervoy    
Revenue from External Customer [Line Items]    
Total Revenues 583 508
Reblozyl    
Revenue from External Customer [Line Items]    
Total Revenues 354 206
Opdualag    
Revenue from External Customer [Line Items]    
Total Revenues 206 117
Abecma    
Revenue from External Customer [Line Items]    
Total Revenues 82 147
Zeposia    
Revenue from External Customer [Line Items]    
Total Revenues 110 78
Breyanzi    
Revenue from External Customer [Line Items]    
Total Revenues 107 71
Camzyos    
Revenue from External Customer [Line Items]    
Total Revenues 84 29
Sotyktu    
Revenue from External Customer [Line Items]    
Total Revenues 44 16
Augtyro    
Revenue from External Customer [Line Items]    
Total Revenues 6 0
Krazati    
Revenue from External Customer [Line Items]    
Total Revenues 21 0
Other Growth products    
Revenue from External Customer [Line Items]    
Total Revenues 319 280
Legacy Portfolio    
Revenue from External Customer [Line Items]    
Total Revenues 7,073 6,919
Eliquis    
Revenue from External Customer [Line Items]    
Total Revenues 3,720 3,423
Revlimid    
Revenue from External Customer [Line Items]    
Total Revenues 1,669 1,750
Pomalyst/Imnovid    
Revenue from External Customer [Line Items]    
Total Revenues 865 832
Sprycel    
Revenue from External Customer [Line Items]    
Total Revenues 374 429
Abraxane    
Revenue from External Customer [Line Items]    
Total Revenues 217 239
Other Legacy products    
Revenue from External Customer [Line Items]    
Total Revenues $ 228 $ 246